Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 76 - 100 of 2342 in total
Sub Class LM ID Name LipidBank ID ▼ KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BL00
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1177
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AM00
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • type II H antigen
GSG1175
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AL00
  • Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • nLc6Cer, i antigen
GSG1174
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • type II B antigen
GSG1172
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • type I B antigen
GSG1171
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AF00
  • GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • type II A antigen
GSG1170
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB00
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • X-hapten, SSEA-1, Lex-5
GSG1168 77240
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BK00
  • Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1167
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC00
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • Lewis a
GSG1166 90292
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI00
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer
GSG1165
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD00
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • H1 glycolipid, type II antigen
GSG1164 28691
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BJ00
  • Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • galgactosyl-paraglobside
GSG1163
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC00
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1162
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC00
  • Forssman antigen
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1161 18056
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AA00
  • Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • paragloboside, nLc4Cer
GSG1157 17006
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AB00
  • Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer
  • asialo-GM1
GSG1156 27938
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR00
  • Cytolipin R
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer
GSG1155
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB00
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • Globoside I/Cytolipin K
GSG1154 18259
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AL00
  • GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer
GSG1039
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AP00
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1021
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO00
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1019
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BT00
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1017
Other Neutral glycosphingolipids LMSP05000001
  • N-(34S-methyl-5Z,9Z,12Z,15Z,18Z,21Z-hexatriacontahexaenoyl)-1-sulfo-beta-D-fucosyl-(16R-methyl-sphing-4-enine)
  • Syriacin
52931241 1059.777221 C62H109NO10S
Other Neutral glycosphingolipids LMSP05000002
  • 1-O-melibiosoyl-(N-(2R-hydroxy-docosanoyl)-4R-hydroxy-heptadecasphinganine)
  • Galalpha1-6Glcbeta-Cer(t17:0/22:0(2OH[R])
171120227 965.701474 C51H99NO15
Other Neutral glycosphingolipids LMSP05000003
  • 1-O-melibiosoyl-(N-(2R-hydroxy-docosanoyl)-4R-hydroxy-16-methyl-hexadecasphinganine)
  • Galalpha1-6Glcbeta-Cer(t17:0/22:0(2OH[R])
171120228 965.701474 C51H99NO15

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024